Recent advances and emerging treatments
暂无分享,去创建一个
The healing of acute wounds involves a complex and dynamic series of events leading to the repair of injured tissues. These events, triggered by tissue injury, involve four overlapping but well defined phases: haemostasis, inflammation, proliferation, and remodelling.
The four phases of acute wound healing
View this table:
Composition of some tissue engineered skin substitutes
Haemostasis is secured by platelet aggregation and clot formation. The inflammatory phase begins with the arrival of phagocytic neutrophils and, later, macrophages at the wound site; they are important sources of and substrates for growth factors. The proliferative phase is characterised by the formation of new blood vessels (angiogenesis), synthesis of extracellular matrix components such as collagen, granulation tissue formation, and re-epithelialisation. The extracellular matrix is continually remodelled during the final phase; an avascular scar is the end result of the healing process.
View this table:
Tissue engineered skin substitutes in wound healing
Chronic wounds may be arrested in any of the four phases; commonly, however, disruption occurs in the inflammatory or the proliferative phases. Many mediators—including inflammatory cells, growth factors, proteases such as matrix metalloproteinases (MMPs), and cellular and extracellular elements—play important roles in different stages of the healing process. Alterations in one or more of these components may account for the impaired healing observed in chronic wounds.
Cryopreserved human cadaver skin (used in the UK), and human amniotic membrane and frog skin (used in other parts of the world) have long been used to treat wounds, particularly burns. More recently, artificial “skin substitutes” and growth factors have been developed to help achieve healing in chronic, non-healing wounds of varying aetiologies. These treatments target different stages of the healing process and, in the case of skin substitutes, replace lost tissue.
Artificial skin substitutes, products of tissue engineering, consist of a microengineered, biocompatible, polymer matrix in combination with cellular and/or extracellular …
[1] E. A. Nelson,et al. Skin grafting for venous leg ulcers. , 2013, The Cochrane database of systematic reviews.
[2] Keith Harding,et al. Science, medicine and the future: healing chronic wounds. , 2002, BMJ.
[3] K. Dunn,et al. Informed consent should be obtained from patients to use products (skin substitutes) and dressings containing biological material , 2005, Journal of Medical Ethics.